光子计数CT评估心脏淀粉样变性的细胞外容积与冠状动脉疾病
研究纳入30例心脏淀粉样变性患者,行第一代光子计数CT冠状动脉CTA及延迟期扫描,比较单能技术和双能技术测量的细胞外容积与心脏磁共振参考标准,并评估冠状动脉疾病。双能法与心脏磁共振差异小且临床不相关,三种方法相关性良好;冠状动脉疾病患病率高,57.6%为非阻塞性。
要点
- 光子计数CT单能技术测量的细胞外容积与心脏磁共振无显著差异,双能技术略低但临床不相关。
- 心脏淀粉样变性患者冠状动脉疾病患病率高达97.0%,其中57.6%为非阻塞性。
- 尽管平均Agatston评分高且47.6%患者合并心房颤动,97.0%患者图像质量仍可保持。
核心结论
- 与心脏磁共振参考标准相比,光子计数CT双能法和单能法测量的细胞外容积均呈极好正相关,双能法与心脏磁共振的微小差异临床不相关;心脏淀粉样变性患者广泛钙化斑块的冠状动脉疾病高发,但57.6%为非阻塞性,光子计数CT是同时评估冠状动脉和心肌结构的有价值工具。
研究设计与样本
- 研究纳入30例心脏淀粉样变性患者(平均年龄77.5±7.9岁),因临床需要行第一代光子计数CT冠状动脉CTA评估冠状动脉疾病,并加做延迟期扫描测量细胞外容积;单能法基于预对比钙化积分扫描与平衡期延迟CTA的衰减变化,双能法基于延迟扫描的碘密度图;以心脏磁共振测得的细胞外容积为影像参考标准。
诊断标准与关键数值
- 心脏磁共振平均细胞外容积42.93±10.14,单能法42.5±9.1,双能法40.7±9.2;双能法与心脏磁共振差异MDiff=-2.24(P=0.04),单能法与心脏磁共振差异MDiff=0.43(P=1.00),双能法与单能法差异MDiff=-1.82(P<0.001);双能法与单能法相关性r=0.98(P<0.001),心脏磁共振与双能法r=0.892(P<0.001),心脏磁共振与单能法r=0.882(P<0.001)。
临床应用与阅片要点
- 在心脏淀粉样变性患者中,光子计数CT单能法测量的细胞外容积与心脏磁共振一致性良好,双能法测量值略低但临床不相关;冠状动脉疾病患病率97.0%,平均Agatston评分1086±1398(范围0-6848.5),其中57.6%为非阻塞性,47.6%患者合并心房颤动但97.0%图像质量保持可评估。
局限性
- 双能法测量的细胞外容积显著低于心脏磁共振(MDiff=-2.24,P=0.04),双能法与单能法间差异显著(MDiff=-1.82,P<0.001)。
- 原文未报告其他局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: In cardiac amyloidosis (CA) protein misfolding and consecutive storage into the extracellular myocardial compartment causes left ventricular hypertrophy and, in later stages of the disease, heart failure. The aim of this study was to compare extracellular volume (ECV) measurements obtained from photon-counting CT (PCCT) to the imaging reference cardiac magnetic resonance imaging (CMR) and to evaluate coronary artery disease (CAD) in a CA cohort.
MATERIALS AND METHODS: Thirty CA patients (mean age 77.5 +/- 7.9 years) underwent clinically indicated coronary CT angiography (CCTA) for the evaluation of CAD on a first-generation PCCT including a late-phase scan for assessment of ECV. ECV in PCCT was derived using 2 different techniques: (I) a single-energy (SE) technique, based on attenuation changes between the precontrast calcium scoring scan and delayed CCTA in the equilibrium phase (II) a dual-energy (DE) technique, based on iodine density maps from the delayed scan. Both methods were compared with CMR-derived ECV. Statistical analysis included repeated-measures analysis of variance (RM-ANOVA) with Bonferroni-adjusted pairwise comparisons. Correlations between methods were assessed using Pearson's correlation coefficient, and agreement was evaluated using Bland-Altman analysis.
RESULTS: CMR exhibited the highest mean ECV value (42.93 ± 10.14), followed by the SE method (42.5 ± 9.1), while the DE method yielded the lowest ECV values (40.7 ± 9.2). When compared with CMR, ECV obtained via the DE method was significantly lower ( MDiff = -2.24, P = 0.04). In contrast, no significant difference was observed between CMR and the SE method ( MDiff = 0.43, P = 1.00). Differences between the DE and SE methods were significant ( MDiff = -1.82, P < 0.001). Despite these differences, all 3 methods demonstrated excellent positive correlations. The strongest correlation was observed between the DE and SE methods ( r = 0.98, P < 0.001), indicating high consistency in their measurements. Comparatively, the correlation between CMR and DE ( r = 0.892, P < 0.001) was slightly stronger than that between CMR and SE methods ( r = 0.882, P < 0.001). CAD was present in 29 (97.0%) CA patients with a mean Agatston score of 1086 ± 1398 (range 0-6848.5). Despite this high mean plaque burden and 14 (47.6%) patients presenting with atrial fibrillation, image quality was preserved in 29 (97.0%) patients with 17 (57.6%) of the patients having nonobstructive CAD.
CONCLUSIONS: Compared to the imaging reference standard CMR, ECV derived from the DE and SE methods via PCCT demonstrated excellent positive correlations with CMR. The DE method exhibited minor differences compared to CMR, which were clinically not relevant. CAD with an extensive burden of calcified plaque was highly prevalent in CA; however, 57.6% of patients presented with nonobstructive CAD. Therefore, PCCT is a valuable tool for imaging both the coronary arteries and myocardial structure in CA.
引用
- Popp S, Beitzke D, Strassl A, et al. Evaluation of Extracellular Volume and Coronary Artery Disease in Cardiac Amyloidosis Using Photon-Counting CT. Invest Radiol. 2025. PMID: 40279664. doi:10.1097/RLI.0000000000001198
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。